Skip to main content

Table 2 Distribution of maternal urinary mycoestrogens (ng/ml) across pregnancy UPSIDE cohort (n = 286)a

From: Urinary mycoestrogens and gestational weight gain in the UPSIDE pregnancy cohort

Analyte

Timing

N

% > LOD

25%

50%

75%

95%

Max

ZEN

1st

271

94.1

0.057

0.096

0.183

0.642

1.457

aZOL

1st

271

74.9

<LOD

0.078

0.164

0.430

1.506

Σmyco

1st

271

94.8

0.101

0.225

0.460

1.337

4.003

ZEN

2nd

264

99.2

0.064

0.115

0.204

0.528

2.966

aZOL

2nd

264

88.3

0.063

0.132

0.240

0.700

2.621

Σmyco

2nd

264

99.2

0.169

0.319

0.547

1.552

7.661

ZEN

3rd

269

93.7

0.099

0.195

0.345

0.973

10.97

aZOL

3rd

269

90.0

0.122

0.230

0.423

1.092

5.620

Σmyco

3rd

269

97.4

0.262

0.481

0.873

2.421

20.581

  1. Abbreviations: aZOL alpha-zearalenol, Max Maximum, Σmyco Sum of mycoestrogen analytes, ZEN Zearalenone
  2. aThe n represents 286 participants contributing data in any trimester. Mycoestrogen concentrations are adjusted for specific gravity